Optimization of DE-CTPA Images and Diagnostic Pathway: Using Low Concentration Iodine Contrast Material
Dual-Energy CT Angiography in Suspected Pulmonary Embolism: Influence of Concentration of Contrast Materials on Image Quality and Diagnostic Performance
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Xiangming Fang, Doctor
- Phone Number: +86 15295557003
- Email: mengxp0711@163.com
Study Locations
-
-
Jiangsu
-
Wuxi, Jiangsu, China, 214043
- Recruiting
- Wuxi People's Hospital
-
Contact:
- Peihua Lu, MD
- Phone Number: +86 13621500031
- Email: 13625653@qq.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age greater than 18 years old
- Clinical suspicion of pulmonary embolism suggests CTPA examination (Wells score>4 or D-2 polymer elevation)
- Patient's general physical condition tolerates CTPA examination
Exclusion Criteria:
- Allergy to iodine contrast agents
- Hyperthyroidism
- Pregnancy
- Weight greater than 80kg
- Heart failure patients, NYHA heart function level III or IV
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Lower concentration and lower volume contrast agent group
|
CT images using lower concentration and lower volume contrast material
|
|
Lower concentration and normal volume contrast agent group
|
CT images using lower concentration and lower volume contrast material
|
|
Normal concentration and normal volume contrast agent group
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
image quality evaluation of the CTPA images of 30% participants
Time Frame: through the CTPA examinations of 30% participants finished,, an average of six month
|
|
through the CTPA examinations of 30% participants finished,, an average of six month
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
overall diagnostic performance for pulmonary embolism
Time Frame: CTPA examinations all participants are finished, an average of two month
|
diagnostic accuracy, sensitivity and specificity
|
CTPA examinations all participants are finished, an average of two month
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimated)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- KY23055
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.